2021年最新SCI期刊影响因子查询系统
Lancet Respiratory Medicine 期刊详细信息
基本信息
期刊名称 | Lancet Respiratory Medicine Lancet Respiratory Medicine |
---|---|
期刊ISSN | 2213-2600 |
期刊官方网站 | http://www.thelancet.com/journals/lanres/onlinefirst |
是否OA | 否 |
出版商 | Elsevier Ltd |
出版周期 | |
始发年份 | |
年文章数 | 66 |
最新影响因子 | 102.642(2021) |
中科院SCI期刊分区
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
医学1区 | CRITICAL CARE MEDICINE 危重病医学1区 | 是 | 否 |
RESPIRATORY SYSTEM 呼吸系统1区 |
CiteScore
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 4.91 | 7.695 | 6.032 |
Medicine Pulmonary and Respiratory Medicine |
5 / 134 | 96% |
补充信息
自引率 | 3.00% |
---|---|
H-index | 53 |
SCI收录状况 |
Science Citation Index Expanded |
官方审稿时间 | |
网友分享审稿时间 | 数据统计中,敬请期待。 |
PubMed Central (PML) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2213-2600%5BISSN%5D |
投稿指南
期刊投稿网址 | http://ees.elsevier.com/thelancetrm/ |
---|---|
收稿范围 | The Lancet Respiratory Medicine delivers comprehensive, clinically-focused coverage on all areas of respiratory medicine and critical care, including but not limited to: COPD, asthma, cystic fibrosis, IPF, pneumonia, influenza, tuberculosis, sarcoidosis, pulmonary hypertension, sleep medicine, respiratory infections, pulmonary vascular disease, lung cancer, tobacco control, thoracic and reconstructive surgery, mesothelioma, and palliative medicine. Continuing in The Lancet's tradition of publishing high-impact content that influences medical practice, each monthly issue of The Lancet Respiratory Medicine contains Original Research, Reviews, Personal Views, Comments, and News. The Lancet Respiratory Medicine is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. Original Research is fast-tracked to publication within 8 weeks of submission (on average) and published Online First on www.thelancet.com before appearing in print. Now indexed in PubMed, Journal Citation Reports®, and Scopus, the journal accepts submissions of Original Research, Reviews, Personal Views, and Comments. Visit http://ees.elsevier.com/thelancetrm to learn more about our editorial scope and aims and to submit your manuscript. Gold or Green Open Access is available for research supported by selected funding agencies with whom Elsevier has an agreement. The journal is also freely available to readers in low-to-middle-income countries via the HINARI programme or via IP access at www.thelancet.com. |
收录体裁 | Editorials Comment Correspondence World Reports and News Perspectives Article Clinical Picture Commissions Health Policy Personal View / Viewpoint Reviews Seminar Series Therapeutics |
投稿指南 | https://www.thelancet.com/what-we-publish |
投稿模板 | |
参考文献格式 | https://www.thelancet.com/what-we-publish |
编辑信息 |